
Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.

In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.

The injection bags will be available in 1000 mg in 100 mL doses, as well as in 500 mg in 50 mL doses.

Nonanastomotic biliary strictures occurred in 6% of the patients in the machine-perfusion group, while the complication occurred in 18% of the control group.

There was no difference in rates of 30-day cardiac mortality and acute myocardial infarction between single troponin test recipients and serial troponin test recipients.

Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.

In the U-ACCOMPLISH study, 37% of patients treated with upadacitinib achieved histologic-endoscopic mucosal improvement at week 8.

Approximately 13.8 million doses of COVID-19 vaccines have been administered during a 1 month period.

Levels of post-illness PTSD is comparable to rates found in other epidemics.

Women were more likely than men to get the influenza vaccine, but less likely to receive the high-dose version.

Missed diagnosis resulted in delays in initiation of therapy and hospital re-admissions.

Researchers find a significant benefit at day 28 when compared to a group taking a placebo.

The number of individuals suffering from vision impairment expected to rise to 895 million by 2050.

The approval was based on data from the PARAGON-HF study.

The investigators found the primary efficacy endpoints occurred in 20 evaluable patients (87%).

Dr. Khan discusses some of the risk factors associated with CHD.

Researchers find higher neurocognitive abilities are associated with an improvement of everyday life.

Researchers found a stable pattern of behavioral inhibition from toddlerhood to childhood predicted greater worry dysregulation in adolescence.

Investigators conclude improvements in kidney transplantation may require significant interventions.

Researchers find an increased risk of offspring ADHD symptoms due to maternal anxiety.

Researchers believe identifying more risk factors could be beneficial in reducing cardiovascular disease.

Linaclotide has been marketed as LINZESS to treat irritable bowel syndrome with constipation.

FLT201 is a combination of AAVS3 capsid and a liver-specific promotor to drive the expression of GCasevar85.

Researchers found a significant association between polygenic risk scores for ADHD and reaction time variability, but not commission errors.

More than 25% of adults in the US older than 65 have diabetes.

Recent clinical trials have shown positive topline results for SPN-812.

The 1 patient who did not received immunomodulatory agents demonstrated the highest level of FVIII activity.

Hydroxyurea therapy was associated with decreased rates of retinal thinning and could be a protective factor.

Participants who received the vaccine intranasally or through the tonsillar swab had significantly higher H5-specific neutralizing antibody levels than the group that received the vaccine orally.

A higher percentage of patients suffering from a severe mental disorder such as schizophrenia or bipolar disorder, died from a COVID-19 infection than the control group.